Antibody Drug Conjugate Market Size Is Projected To Reach USD 23.9 Billion By 2028
San Francisco, 19 Oct 2021: The Report Antibody Drug Conjugate Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer), By Technology (Cleavable Linker, Linkerless), By Region, And Segment Forecasts, 2021 - 2028 The global antibody drug conjugate market size is expected to reach USD 23.9 billion by 2028, according to a new report by Grand View Research Inc. The market is expected to grow at a CAGR of 23.7% from 2021 to 2028. Increasing investment in R&D and advancements in linker technology are expected to boost the growth of the antibody drug conjugates (ADCs) market. Antibody-drug conjugates are a novel category of drugs composed of an antibody linked to a cytotoxic drug with a linker. Conventional chemotherapy is intended to kill fast-growing tumor cells. However, it can also damage healthy proliferating cells, which may produce undesirable effects. In contrast, ADCs are designed to increase the efficacy of ...